Recent Finacing
Recent Raise
Damona develops small-molecule GABA modulators targeting impaired brain receptors to restore cognition; preclinical-stage lead AC-101 is licensed from CAMH, UWM Research Foundation, University of Tours, and University of Belgrade.
Focus Areas
Recent Investors
Funding round
Investors
